{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:17:55Z","timestamp":1793711875707,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873906"],"award-info":[{"award-number":["81873906"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171985"],"award-info":[{"award-number":["82171985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Opening foundation of Hubei Key Laboratory of Molecular Imaging","award":["02.03.2018-87"],"award-info":[{"award-number":["02.03.2018-87"]}]},{"name":"Wuhan Young and Middle-aged Medical Backbone Talent Training Project","award":["02.05.1803004"],"award-info":[{"award-number":["02.05.1803004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammatory regulation induced by macrophage polarization is essential for cardiac repair after myocardial infarction (MI). Berberin (BBR) is an isoquinoline tetrasystemic alkaloid extracted from plants. This study analyzes the most likely mechanism of BBR in MI treatment determined via network pharmacology, showing that BBR acts mainly through inflammatory responses. Because platelets (PLTs) can be enriched in the infarcted myocardium, PLT membrane-coated polylactic-co-glycolic acid (PLGA) nanoparticles (BBR@PLGA@PLT\u00a0NPs) are used, which show enrichment in the infarcted myocardium to deliver BBR sustainably. Compared with PLGA nanoparticles, BBR@PLGA@PLT NPs\u00a0are more enriched in the infarcted myocardium and exhibit less uptake in the liver. On day three after MI, BBR@PLGA@PLT NPs\u00a0administration significantly increases the number of repaired macrophages and decreases the number of inflammatory macrophages and apoptotic cells in infarcted rat myocardium. On the 28th day after MI, the BBR@PLGA@PLT group exhibits a protective effect on cardiac function, reduced cardiac collagen deposition, improved scar tissue stiffness, and an excellent angiogenesis effect. In addition, BBR@PLGA@PLT group\u00a0has no significant impact on major organs either histologically or enzymologically. In summary, the therapeutic effect of BBR@PLGA@PLT NPs\u00a0on MI is presented in detail from the perspective of the resolution of inflammation, and a new solution for MI treatment is proposed.<\/jats:p><jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-023-01790-w","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:04:57Z","timestamp":1674900297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Berberin sustained-release nanoparticles were enriched in infarcted rat myocardium and resolved inflammation"],"prefix":"10.1186","volume":"21","author":[{"given":"Ke","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmeihui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyongxue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141:e139\u2013596.","journal-title":"Circulation"},{"key":"1790_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11:255\u201365.","journal-title":"Nat Rev Cardiol"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"1790_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24\u201335.","journal-title":"J Mol Cell Cardiol"},{"key":"1790_CR5","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.117.031046","volume":"137","author":"DJ Cao","year":"2018","unstructured":"Cao DJ, Schiattarella GG, Villalobos E, Jiang N, May HI, Li T, Chen ZJ, Gillette TG, Hill JA. Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation. 2018;137:2613\u201334.","journal-title":"Circulation"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.116.310260","volume":"120","author":"X Yan","year":"2017","unstructured":"Yan X, Zhang H, Fan Q, Hu J, Tao R, Chen Q, Iwakura Y, Shen W, Lu L, Zhang Q, Zhang R. Dectin-2 deficiency modulates Th1 differentiation and improves wound healing after myocardial infarction. Circ Res. 2017;120:1116\u201329.","journal-title":"Circ Res"},{"key":"1790_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","volume":"139","author":"Q Fan","year":"2019","unstructured":"Fan Q, Tao R, Zhang H, Xie H, Lu L, Wang T, Su M, Hu J, Zhang Q, Chen Q, et al. Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration. Circulation. 2019;139:663\u201378.","journal-title":"Circulation"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ptr.2399","volume":"22","author":"M Imanshahidi","year":"2008","unstructured":"Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:999\u20131012.","journal-title":"Phytother Res"},{"key":"1790_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1527-3466.2001.tb00068.x","volume":"19","author":"CW Lau","year":"2001","unstructured":"Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev. 2001;19:234\u201344.","journal-title":"Cardiovasc Drug Rev"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"118903","DOI":"10.1016\/j.lfs.2020.118903","volume":"266","author":"T Yang","year":"2021","unstructured":"Yang T, Wang R, Liu H, Wang L, Li J, Wu S, Chen X, Yang X, Zhao Y. Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in helicobacter pylori-induced chronic atrophic gastritis. Life Sci. 2021;266:118903.","journal-title":"Life Sci"},{"key":"1790_CR11","doi-asserted-by":"crossref","first-page":"289264","DOI":"10.1155\/2014\/289264","volume":"2014","author":"Z Li","year":"2014","unstructured":"Li Z, Geng YN, Jiang JD, Kong WJ. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med. 2014;2014:289264.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1790_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2015.05.028","volume":"762","author":"Z Huang","year":"2015","unstructured":"Huang Z, Han Z, Ye B, Dai Z, Shan P, Lu Z, Dai K, Wang C, Huang W. Berberine alleviates cardiac ischemia\/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol. 2015;762:1\u201310.","journal-title":"Eur J Pharmacol"},{"key":"1790_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/1440-1681.12309","volume":"41","author":"YJ Zhang","year":"2014","unstructured":"Zhang YJ, Yang SH, Li MH, Iqbal J, Bourantas CV, Mi QY, Yu YH, Li JJ, Zhao SL, Tian NL, Chen SL. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol. 2014;41:995\u20131002.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","volume":"243","author":"A Pirillo","year":"2015","unstructured":"Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis. 2015;243:449\u201361.","journal-title":"Atherosclerosis"},{"key":"1790_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1039\/C4MB00500G","volume":"11","author":"S Gu","year":"2015","unstructured":"Gu S, Cao B, Sun R, Tang Y, Paletta JL, Wu X, Liu L, Zha W, Zhao C, Li Y, et al. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol Biosyst. 2015;11:463\u201374.","journal-title":"Mol Biosyst"},{"key":"1790_CR16","doi-asserted-by":"publisher","first-page":"9987097","DOI":"10.1155\/2021\/9987097","volume":"2021","author":"Y Han","year":"2021","unstructured":"Han Y, Xiang Y, Shi Y, Tang X, Pan L, Gao J, Bi R, Lai X. Pharmacokinetics and pharmacological activities of Berberine in diabetes mellitus treatment. Evid Based Complement Alternat Med. 2021;2021:9987097.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1790_CR17","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2217\/nnm-2017-0225","volume":"12","author":"A Narain","year":"2017","unstructured":"Narain A, Asawa S, Chhabria V, Patil-Sen Y. Cell membrane coated nanoparticles: next-generation therapeutics. Nanomed (Lond). 2017;12:2677\u201392.","journal-title":"Nanomed (Lond)"},{"key":"1790_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","volume":"327","author":"P Dash","year":"2020","unstructured":"Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers\u2014an efficient biomimetic platform for targeted therapy. J Control Release. 2020;327:546\u201370.","journal-title":"J Control Release"},{"issue":"16","key":"1790_CR19","doi-asserted-by":"publisher","first-page":"1606209","DOI":"10.1002\/adma.201606209","volume":"29","author":"D Dehaini","year":"2017","unstructured":"Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29:1606209.","journal-title":"Adv Mater"},{"key":"1790_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15373","volume":"526","author":"CM Hu","year":"2015","unstructured":"Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526:118\u201321.","journal-title":"Nature"},{"issue":"4","key":"1790_CR21","doi-asserted-by":"publisher","first-page":"1803567","DOI":"10.1002\/adfm.201803567","volume":"29","author":"T Su","year":"2019","unstructured":"Su T, Huang K, Ma H, Liang H, Dinh PU, Chen J, Shen D, Allen TA, Qiao L, Li Z, et al. Platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury. Adv Funct Mater. 2019;29:1803567.","journal-title":"Adv Funct Mater"},{"key":"1790_CR22","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.7150\/thno.27466","volume":"8","author":"M Li","year":"2018","unstructured":"Li M, Liu Y, Chen J, Liu T, Gu Z, Zhang J, Gu X, Teng G, Yang F, Gu N. Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics. Theranostics. 2018;8:4870\u201383.","journal-title":"Theranostics"},{"key":"1790_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","volume":"102","author":"B Nieswandt","year":"2003","unstructured":"Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102:449\u201361.","journal-title":"Blood"},{"key":"1790_CR24","doi-asserted-by":"crossref","unstructured":"Hu S, Wang X, Li Z, Zhu D, Cores J, Wang Z, Li J, Mei X, Cheng X, Su T, Cheng K. Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano Today. 2021;39:101210.","DOI":"10.1016\/j.nantod.2021.101210"},{"key":"1790_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","volume":"159","author":"M Mir","year":"2017","unstructured":"Mir M, Ahmed N, Rehman AU. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces. 2017;159:217\u201331.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1790_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","volume":"6","author":"DN Kapoor","year":"2015","unstructured":"Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a unique polymer for drug delivery. Ther Deliv. 2015;6:41\u201358.","journal-title":"Ther Deliv"},{"key":"1790_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11239-019-02022-5","volume":"49","author":"MK Anwer","year":"2020","unstructured":"Anwer MK, Mohammad M, Iqbal M, Ansari MN, Ezzeldin E, Fatima F, Alshahrani SM, Aldawsari MF, Alalaiwe A, Alzahrani AA, Aldayel AM. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect. J Thromb Thrombolysis. 2020;49:404\u201312.","journal-title":"J Thromb Thrombolysis"},{"key":"1790_CR28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/IJN.S195048","volume":"14","author":"MK Anwer","year":"2019","unstructured":"Anwer MK, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomed. 2019;14:1587\u201395.","journal-title":"Int J Nanomed"},{"key":"1790_CR29","doi-asserted-by":"publisher","first-page":"111029","DOI":"10.1016\/j.msec.2020.111029","volume":"114","author":"M Chatterjee","year":"2020","unstructured":"Chatterjee M, Jaiswal N, Hens A, Mahata N, Chanda N. Development of 6-thioguanine conjugated PLGA nanoparticles through thioester bond formation: benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications. Mater Sci Eng C Mater Biol Appl. 2020;114:111029.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1790_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7150\/thno.47841","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11:164\u201380.","journal-title":"Theranostics"},{"key":"1790_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/17425247.5.6.615","volume":"5","author":"SD Allison","year":"2008","unstructured":"Allison SD. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv. 2008;5:615\u201328.","journal-title":"Expert Opin Drug Deliv"},{"key":"1790_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2016.12.042","volume":"247","author":"IE Allijn","year":"2017","unstructured":"Allijn IE, Czarny BMS, Wang X, Chong SY, Weiler M, da Silva AE, Metselaar JM, Lam CSP, Pastorin G, de Kleijn DPV, et al. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Control Release. 2017;247:127\u201333.","journal-title":"J Control Release"},{"key":"1790_CR33","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1021\/acs.molpharmaceut.1c00145","volume":"18","author":"L Xu","year":"2021","unstructured":"Xu L, Chen Y, Jin Q, Wu Y, Deng C, Zhong Y, Lin L, Chen L, Fu W, Yi L, et al. Biomimetic PLGA microbubbles coated with platelet membranes for early detection of myocardial ischaemia-reperfusion injury. Mol Pharm. 2021;18:2974\u201385.","journal-title":"Mol Pharm"},{"key":"1790_CR34","doi-asserted-by":"publisher","first-page":"11166","DOI":"10.1021\/acsomega.1c07335","volume":"7","author":"K Wang","year":"2022","unstructured":"Wang K, Qian R, Li H, Wang C, Ding Y, Gao Z. Interpreting the pharmacological mechanisms of sho-saiko-to on thyroid carcinoma through combining network pharmacology and experimental evaluation. ACS Omega. 2022;7:11166\u201376.","journal-title":"ACS Omega"},{"key":"1790_CR35","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.2174\/1381612826666201112142408","volume":"27","author":"L Gao","year":"2021","unstructured":"Gao L, Cao M, Li JQ, Qin XM, Fang J. Traditional chinese medicine network pharmacology in cardiovascular precision medicine. Curr Pharm Des. 2021;27:2925\u201333.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"1790_CR36","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","volume":"19","author":"P Qiao","year":"2022","unstructured":"Qiao P, Wang Y, Zhu K, Zheng D, Song Y, Jiang D, Qin C, Lan X. Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using (68)Ga-FAPI-04 PET\/CT. Mol Pharm. 2022;19:4171\u201378.","journal-title":"Mol Pharm"},{"key":"1790_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112:33.","journal-title":"Basic Res Cardiol"},{"key":"1790_CR38","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1038\/s41467-019-10859-w","volume":"10","author":"H Abe","year":"2019","unstructured":"Abe H, Takeda N, Isagawa T, Semba H, Nishimura S, Morioka MS, Nakagama Y, Sato T, Soma K, Koyama K, et al. Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. Nat Commun. 2019;10:2824.","journal-title":"Nat Commun"},{"key":"1790_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/ejhf.1596","volume":"21","author":"SD Anker","year":"2019","unstructured":"Anker SD, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Brueckmann M, et al. Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-preserved trial. Eur J Heart Fail. 2019;21:1279\u201387.","journal-title":"Eur J Heart Fail"},{"key":"1790_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12951-022-01432-7","volume":"20","author":"K Zhu","year":"2022","unstructured":"Zhu K, Jiang D, Wang K, Zheng D, Zhu Z, Shao F, Qian R, Lan X, Qin C. Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET\/CT. J Nanobiotechnology. 2022;20:211.","journal-title":"J Nanobiotechnology"},{"key":"1790_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2015.06.036","volume":"213","author":"Y Yang","year":"2015","unstructured":"Yang Y, Shi C, Hou X, Zhao Y, Chen B, Tan B, Deng Z, Li Q, Liu J, Xiao Z, et al. Modified VEGF targets the ischemic myocardium and promotes functional recovery after myocardial infarction. J Control Release. 2015;213:27\u201335.","journal-title":"J Control Release"},{"key":"1790_CR42","first-page":"18","volume":"1","author":"M Tian","year":"2015","unstructured":"Tian M, Yuan YC, Li JY, Gionfriddo MR, Huang RC. Tumor necrosis factor-\u03b1 and its role as a mediator in myocardial infarction: a brief review. Chronic Dis Transl Med. 2015;1:18\u201326.","journal-title":"Chronic Dis Transl Med"},{"key":"1790_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10495-017-1438-3","volume":"23","author":"AA Jarrah","year":"2018","unstructured":"Jarrah AA, Schwarskopf M, Wang ER, LaRocca T, Dhume A, Zhang S, Hadri L, Hajjar RJ, Schecter AD, Tarzami ST. SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis. 2018;23:79\u201391.","journal-title":"Apoptosis"},{"key":"1790_CR44","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/clinchem\/27.11.1845","volume":"27","author":"MP Visser","year":"1981","unstructured":"Visser MP, Krill MT, Muijtjens AM, Willems GM, Hermens WT. Distribution of enzymes in dog heart and liver; significance for assessment of tissue damage from data on plasma enzyme activities. Clin Chem. 1981;27:1845\u201350.","journal-title":"Clin Chem"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01790-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T05:40:45Z","timestamp":1728798045000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01790-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were approved by Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. All animal experiments were conformed to the guidelines and standards of the Experimental Animal Center of Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}